company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20400000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,903000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6227000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11809000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1461000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1461000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-552000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-121000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-673000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-673000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-554000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,238000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-316000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-316000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2450000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30302000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30302000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2282000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11878000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3781000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12361000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12361000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-364000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-174000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-538000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-538000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-556000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,55156000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2624000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57224000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57224000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44325000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,182000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37949000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37949000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,946000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21356000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1622000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17269000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17269000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-423000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-241000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-664000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-664000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-374000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4375000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1402000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7256000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12659000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12659000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:31:13+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5274000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47762000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47762000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1147000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25089000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3354000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18172000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18172000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-554000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-171000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-725000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-725000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-364000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2257000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-503000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1390000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1390000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17507000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13910000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13910000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1500000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-13443000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2876000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4843000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4843000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-170000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-151000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-321000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-321000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-363000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8889000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7580000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,946000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,946000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5468000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51802000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51802000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1021000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22332000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5785000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22664000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22664000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-305000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-413000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-413000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-365000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,235301000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8080000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,243016000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,243016000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,219939000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,230000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51312000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51312000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5618000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4849000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3249000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37596000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37596000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1050000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-270000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,89554000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-89754000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1520000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1520000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-364000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2304000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-313000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1627000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1627000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-37489000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53213000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53213000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,854000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2992000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4934000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44433000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44433000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1088000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-163000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89554000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24500000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,89466000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23161000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23161000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-363000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2521000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2158000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2158000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19114000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60453000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60453000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,813000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8598000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9951000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41091000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41091000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1370000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18624000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18624000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-362000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2309000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1720000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,227000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,227000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22240000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,206000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64670000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64670000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,811000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4353000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8944000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-68450000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-68450000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1147000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6133000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12720000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12720000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-537000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,311559000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1392000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,309630000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,309630000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,22000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:31:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,253922000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68985000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68985000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,958000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12305000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10028000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45694000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45694000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-602000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4398000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4398000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-528000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,822000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-361000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-67000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-67000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-47000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41410000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66340000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66340000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1078000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5298000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3795000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-56169000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56169000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3875000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6125000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6125000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-525000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3288000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-169000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2594000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2594000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-47455000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74163000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74163000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1289000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10475000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10830000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51569000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51569000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2919000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4186000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2895000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2895000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-525000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,652000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1427000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1427000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-47257000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,153000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,17000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49822000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49822000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1297000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6886000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10770000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-52409000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-52409000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1706000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1706000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1706000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1050000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1358000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-398000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-90000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-90000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 16:31:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-54206000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56921000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56921000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1525000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7548000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4162000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43686000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43686000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-304000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-304000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-304000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8050000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,194000000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28484000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-43380000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,171054000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,171054000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,127066000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50108000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3257000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7637000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3379000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35835000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35835000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-465000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-465000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-465000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1079000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,797000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-158000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-440000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-440000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,152000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36588000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5751000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5751000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2735000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5683000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,71469000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,74136000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,74136000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-312000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,4768000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4456000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4456000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7079000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,636000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7179000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,536000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,536000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,109000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,79237000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,8077000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,185000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52676000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52676000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2859000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8434000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8811000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-50194000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50194000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-754000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-754000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-754000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1320000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,731000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2051000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2051000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,225000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48672000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:43:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63159000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63159000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2903000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10644000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21189000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28423000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28423000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1946000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1946000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1946000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-890000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,410000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,410000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-91000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30050000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55450000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55450000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3257000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9931000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,221000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42041000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42041000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1746000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1746000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1746000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-313000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,976000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,51654000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52317000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52317000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-309000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8221000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59871000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59871000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3736000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,128000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17420000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38587000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38587000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12759000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12759000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12759000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1064000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,840000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-297000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-521000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-521000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,568000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-51299000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,7259000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,238000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53787000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53787000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3520000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5433000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20261000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65095000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65095000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15300000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-973000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,777000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10674000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10478000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10478000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-44000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-69961000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q1,2016-01-01,2016-03-31,2016-05-10 16:43:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,109848000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109848000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3780000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-127264000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19016000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32652000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32652000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16204000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,144847000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,128643000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,128643000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1916000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3297000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14748000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16129000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16129000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,112120000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27827000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27827000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4317000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2357000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2536000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23689000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23689000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8068000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-1698000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9766000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9766000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1924000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10160000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,57210000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,65446000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,65446000.0
ARIAD Pharmaceuticals Inc,ARIA,549300XQ24MXF2Y7K535,0000884731,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31991000.0
